A Chinese herbal drug that is strikingly effective against malaria is in critically short supply because of rising demand, public health officials and pharmaceutical executives say.
As a result, prices for the drug, artemisinin, have quadrupled, and the few companies that make compounds containing it have drastically cut back production. Supply crises are looming in 40 tropical countries that have recently made it the centerpiece of their anti-malarial efforts.
PHOTO: AP
Malaria kills about 1 million people a year, most of them children. Strains resistant to older drugs have spread rapidly, and artemisinin (pronounced are-TEM-is-in-in), which is extracted from the sweet wormwood plant, was embraced this year by Western health agencies and donors as the most cost-effective solution.
The sudden shortage "has created a major wave of shock in our organization," said Dr. Andrea Bosman of the World Health Organization's malaria control team. Paul Lalvani, procurement manager for the Global Fund to Fight AIDS, Tuberculosis and Malaria, said the countries that had just adopted the drug were "really in a bind."
While other drugs are available, switching to a new one takes up to a year and can create dangerous confusion, especially in a poor country, he explained; the new drug must be registered, doctors and nurses must be retrained in dosages and side effects, and rural pharmacies must be alerted and restocked.
"Now they're sitting on the fence wondering if they should go ahead, or wait until the price drops, or pick another drug," he said.
Wormwood is an ancient Asian fever treatment, and Chinese military doctors trying to aid the Vietcong in the 1970s proved that its extracts kill malaria parasites. It has been popular in Southeast Asia, but was largely ignored in the West until this year.
Although sweet wormwood grows wild around the world, virtually all of the cultivation is in the hills of China and Vietnam.
Each crop must be planted in January, harvested in the fall, and then dried and processed. Some would-be growers outside China are complaining that they cannot buy seeds.
The shortage began soon after a series of meetings in April at which the Global Fund, the WHO, the World Bank, UNICEF, the US Agency for International Development and other donors jointly announced that they wanted malaria-prone countries to phase out older drugs like chloroquine and sulfadoxine-pyrimethamine and adopt multidrug combinations containing artemisinin or its derivatives artemether or artesunate.
Even though the new drugs cost 10 times to 20 times as much, the donors chose them because resistance to older drugs was running as high as 60 percent in parts of Africa. (A typical adult course of 24 of the newer pills costs the WHO US$2.40, as against US$20 for chloroquine.)
Until early this year, the world consumed about 30 tonnes of raw artemisinin a year, mostly in Asia, and the price had been steady for several years at about US$230 a kilogram.
But immediately after the WHO's April forecast that the world would need 130 tonnes to 220 tonnes next year, the price rose to US$360 a kilogram. It is now US$750 to US$910 a kilogram.
Drug companies in Switzerland and India say they cannot get enough at any price, and blame is being directed at all corners.
Lalvani, the Global Fund procurement specialist, said the refiners stopped selling this summer, "waiting for the prices to stabilize or go higher."
Pradeep Nambiar, an executive at Ipca Laboratories, an Indian company, said that its Chinese suppliers had reneged on contracts and that he believed they could be "holding back stock anticipating a price rise."
The most vivid evidence of the shortage emerged last Monday, when Novartis, a major Swiss drug company, said it could produce only about half of the 4.5 million courses of its Co-Artem drug that it had promised to deliver to the WHO by March. Its lone artemisinin supplier in China had fallen short, it said.
Co-Artem is the only malaria drug prequalified by the WHO, an endorsement of its safety.
It also combines two drugs in one pill, making it harder for a patient to give away or sell part of a dose.
SEEKING CHANGE: A hospital worker said she did not vote in previous elections, but ‘now I can see that maybe my vote can change the system and the country’ Voting closed yesterday across the Solomon Islands in the south Pacific nation’s first general election since the government switched diplomatic allegiance from Taiwan to Beijing and struck a secret security pact that has raised fears of the Chinese navy gaining a foothold in the region. The Solomon Islands’ closer relationship with China and a troubled domestic economy weighed on voters’ minds as they cast their ballots. As many as 420,000 registered voters had their say across 50 national seats. For the first time, the national vote also coincided with elections for eight of the 10 local governments. Esther Maeluma cast her vote in the
Nearly half of China’s major cities are suffering “moderate to severe” levels of subsidence, putting millions of people at risk of flooding, especially as sea levels rise, according to a study of nationwide satellite data released yesterday. The authors of the paper, published by the journal Science, found that 45 percent of China’s urban land was sinking faster than 3mm per year, with 16 percent at more than 10mm per year, driven not only by declining water tables, but also the sheer weight of the built environment. With China’s urban population already in excess of 900 million people, “even a small portion
UNSETTLING IMAGES: The scene took place in front of TV crews covering the Trump trial, with a CNN anchor calling it an ‘emotional and unbelievably disturbing moment’ A man who doused himself in an accelerant and set himself on fire outside the courthouse where former US president Donald Trump is on trial has died, police said yesterday. The New York City Police Department (NYPD) said the man was declared dead by staff at an area hospital. The man was in Collect Pond Park at about 1:30pm on Friday when he took out pamphlets espousing conspiracy theories, tossed them around, then doused himself in an accelerant and set himself on fire, officials and witnesses said. A large number of police officers were nearby when it happened. Some officers and bystanders rushed
HYPOCRISY? The Chinese Ministry of Foreign Affairs yesterday asked whether Biden was talking about China or the US when he used the word ‘xenophobic’ US President Joe Biden on Wednesday called for a hike in steel tariffs on China, accusing Beijing of cheating as he spoke at a campaign event in Pennsylvania. Biden accused China of xenophobia, too, in a speech to union members in Pittsburgh. “They’re not competing, they’re cheating. They’re cheating and we’ve seen the damage here in America,” Biden said. Chinese steel companies “don’t need to worry about making a profit because the Chinese government is subsidizing them so heavily,” he said. Biden said he had called for the US Trade Representative to triple the tariff rates for Chinese steel and aluminum if Beijing was